Share
News
-
17 June 2013 /News - miscellaneous
Danish Pharmacovigilance Update, 23 May 2013
In this issue of Danish Pharmacovigilance Update: Cases of necrotising fasciitis associated with the use of bevacizumab (Avastin®).
-
10 June 2013 /News - miscellaneous
DKMAnet and indlaegsseddel.dk will be unavailable from 14 June at 13:00 to 18 June at 7:00
During the above period, we will be updating a number of systems, which means it will not be possible to log in or use any of the DKMAnet services or indlaegsseddel.dk.
-
29 May 2013 /News - miscellaneous
Danish Pharmacovigilance Update, 25 April 2013
In this issue of Danish Pharmacovigilance Update: Cerebral haemorrhage in association with the use of methylphenidate (Ritalin® etc.).
-
28 May 2013 /News - miscellaneous
Painkillers to be prescription only in Denmark from 30 September 2013
The Danish Health and Medicines Authority has decided that large packs of mild painkillers will be prescription-only in Denmark from 30 September 2013. From this date, it will only be possible to buy small packs of mild painkillers over the counter. There will be no changes to dispensing status of the medicines that can be bought over the counter after 30 September.
-
15 May 2013 /News - miscellaneous
Information about biosimilar medicines
The European Commission has published a document about biosimilar medicines titled 'What you need to know about Biosimilar Medicinal Products – A consensus information document.'
-
25 April 2013 /News - miscellaneous
Danish Pharmacovigilance Update, 21 March 2013
In this issue of Danish Pharmacovigilance Update: Depressive and suicidal thoughts following discontinuation of varenicline (Champix®).
-
25 April 2013 /News - miscellaneous
Danish Pharmacovigilance Update, 21 February 2013
In this issue of Danish Pharmacovigilance Update: Cardiovascular monitoring when initiating and re-initiating treatment with fingolimod (Gilenya®).
-
08 April 2013 /News - miscellaneous
Painkillers to be prescription only in Denmark
In Denmark, it will soon only be possible to buy large packs of mild painkillers when prescribed by a doctor. The aim is to reduce poisoning incidents and the need for liver transplants.
-
26 March 2013 /News - miscellaneous
Danish Pharmacovigilance Update, 17 January 2013
In this issue of Danish Pharmacovigilance Update: The Pharmacovigilance Risk Assessment Committee, PRAC, finds that the risks outweigh the benefits from the use of Tredaptive®
-
17 January 2013 /News - miscellaneous
Danish Pharmacovigilance Update, 20 December 2012
In this issue of Danish Pharmacovigilance Update: The Danish Health and Medicines Authority encourages doctors to be aware of suspected long-term adverse reactions from the use of SSRIs in children and adolescents.
-
17 January 2013 /News - miscellaneous
Danish Pharmacovigilance Update, 15 November 2012
In this issue of Danish Pharmacovigilance Update: Chlorhexidine and the risk of anaphylactic reaction.
-
15 November 2012 /News - miscellaneous
Danish Pharmacovigilance Update, 18 October 2012
In this issue of Danish Pharmacovigilance Update, read about: Risk of developing hepatotoxicity in patients undergoing treatment with agomelatine (Valdoxan®)
-
17 October 2012 /News - miscellaneous
Danish Pharmacovigilance Update, 20 September 2012
Among the topics covered in this issue of Danish Pharmacovigilance Update are: New definition of adverse reactions due to new European legislation on pharmacovigilance.
-
10 October 2012 /News - miscellaneous
Contaminated medication possibly linked to several meningitis outbreaks in the USA
The health authorities in the USA are presently investigating the cause of a large number of meningitis outbreaks caused by the fungus Aspergillus. In the USA, only those who received the medication in question have been infected, and there have been no reports of transmission from persons to person.
-
05 October 2012 /News - miscellaneous
Warning against illegal potency enhancers
The Danish Health and Medicines Authority warns against widespread sale of illegal potency enhancers. Over the first nine months of 2012, the Danish Health and Medicines Authority was made aware of 54 illegal potency-enhancing products found to contain active pharmaceutical ingredients not declared anywhere on the package or in the product information. The findings are a result of international cooperation.
-
04 October 2012 /News - miscellaneous
INTERPOL-coordinated operation against illegal internet sale of medicines
Last week, the Danish Health and Medicines Authority took place in a global operation code-named PANGEA V against illegal online trading of medicines together with the Danish tax and customs authorities (SKAT), the Danish Police and the Danish Veterinary and Food Administration. The operation was joined by more than 190 authorities from 100 countries all over the world.
-
06 September 2012 /News - miscellaneous
Danish Pharmacovigilance Update, 16 August 2012
Among the topics covered in this issue of Danish Pharmacovigilance Update are: Maximum single dose of intravenous ondansetron (Zofran® and others) now restricted to 16 mg.
-
03 August 2012 /News - miscellaneous
Danish Pharmacovigilance Update, 21 June 2012
Among the topics covered in this issue of Danish Pharmacovigilance Update are: Decrease in the number of intoxications and suicide attempts using drugs containing acetylsalicylic acid or paracetamol.
-
31 July 2012 /News - miscellaneous
Danish Pharmacovigilance Update, 24 May 2012
Among the topics covered in this issue of Danish Pharmacovigilance Update are: Drug Analysis Prints involving data from more than 14,000 Danish adverse reaction reports available at the Danish Health and Medicines Authority’s website.
-
04 July 2012 /News - miscellaneous
Danish Pharmacovigilance Update, 19 April 2012
Among the topics covered in this issue of Danish Pharmacovigilance Update are: Split and crushed tablets containing finasteride may pose a risk for pregnant and fertile women.
